Trice Medical continues mission of making elective procedures more efficient through the acquisition of Tenex Health.
Malvern, PA (April 1st, 2021) – Trice Medical announced today that it has acquired Tenex Health, a leader in minimally invasive ultrasonic technology for the treatment of chronic pain in soft tissue and bone.
Trice Medical is known for its disruptive imaging technology that enables orthopedic procedures to be performed on its portable, tablet-based system. Trice developed the world’s first and only platform that combines a disposable needle camera (mi-eye™) with a high-quality 15mghz ultrasound transducer (mi-ultra™). In 2019, Trice acquired Seg-WAY™ Orthopedics, where their endoscopic carpal tunnel release system was made fully disposable and combined with mi-eye, becoming the first company in the world to enable surgeons to perform this procedure anywhere: in the operating room; a procedure room; or in the office.
The addition of Tenex to the portfolio continues this strategy of improving cost efficiencies, by providing an alternative, minimally invasive treatment for patients suffering from tendonitis in the elbow, hip, knee, ankle, and plantar fasciitis pain in the foot, that can also be performed anywhere. The Trice imaging system is portable and has both arthroscopy and ultrasound capabilities. Most Tenex procedures are performed with ultrasound imaging, so the acquisition will create more therapeutic procedures that can be used with the system.
“We are extremely excited to add this effective and innovative technology to our portfolio and build on our combined strengths,” said Mark Foster, CEO and President of Trice Medical. “Hospitals are driving many large-joint and spine procedures into the surgery center. We believe there are several extremities procedures that can be driven further down the chain into the procedure rooms, without the need for the infrastructure, staff, and costs of the operating rooms. Our mission is to provide products that can help with this transition. We are building a big business in small procedures!”
“Tenex has spent significant time and energy over the past few years to find an ideal partner in order to unleash the potential of our products that benefits the patients, physicians, employees, and stakeholders. We are confident we have found that partner in Trice and see a bright future for the combined organization,” said Chuck Grant, CEO of Tenex Health.
With over 117,000 successful cases since launch, the Tenex Health technology improves overall functionality and significantly decreases pain by removing the source of pain, which is the damaged tissue, and helps stimulate a renewed healing response. In May 2019, Tenex added to their growing Tenex TX system family with the TX-Bone, for the percutaneous removal of calcification, osteophytes, and spur formations. The TX-Bone patented technology also provides an effective treatment option for diabetic foot ulcers, significantly reducing the recurrence rate in patients at less than 5%, compared to a 40-65% recurrence rate in conventional treatments.
“Trice and Tenex have both held a common vision for reducing the cost of care by increasing access to advanced technologies. We believe the combination of these pioneering technologies and complementary product portfolios will accelerate both awareness and adoption of products within each market, providing even greater benefit to an expanded patient population,” said Mike Steen, COO of Tenex Health.
About Trice Medical:
At Trice Medical we continuously strive to improve physician experience and patient outcomes by delivering cutting-edge, minimally invasive, imaging solutions for faster diagnosis and recovery. We are consistently developing new products to enhance our portfolio and partnering with experts in the medical field to deliver the latest advancements in diagnostic and surgical care. To learn more about Trice Medical, headquartered in Malvern, PA, visit www.tricemedical.com.
Contact:
Trice Medical
(610) 989-8080
press@TriceMedical.com
Malvern, PA (May 24th, 2021) – Trice Medical announced today the appointment of Ryan Hartman as Chief Commercial Officer.
Mr. Hartman brings with him over twenty years of healthcare experience, of which the last nineteen years were with Boston Scientific. He received his Bachelor of Arts from SUNY, New Paltz and his Master of Science from New School University.
He will be responsible for developing and executing the Global Marketing strategy including; Health Economics and Reimbursement, Clinical Strategy and Product Development across Trice Medical’s growing, innovative business.
Over the course of his career, Mr. Hartman advanced through multiple leadership roles within Sales, Marketing and Market Development. In his most recent position as Vice President for Single-Use Scopes and Global Markets, Mr. Hartman was instrumental in positioning Boston Scientific as a global leader in the Gastrointestinal Single Use Endoscopy space, where he led a team that would be the first to launch several disruptive disposable endoscopes.
Trice Medical is known for its disruptive imaging technology that enables orthopedic procedures to be performed on its portable, tablet-based system. Trice developed the world’s first and only platform that combines a disposable needle camera (mi-eye™) with a high-quality 15mghz ultrasound transducer (mi-ultra™). In 2020, Trice launched a fully-disposable endoscopic carpal tunnel system with the disposable mi-eye angled camera, making Trice the first company in the world to enable surgeons to perform this procedure anywhere: in the operating room; a procedure room; or in the office. In 2021, Trice acquired Tenex Health, whose cutting-edge, minimally invasive technology improves overall functionality and significantly decreases pain, by precisely targeting and removing damaged tissue and bone without the need for conventional surgery.
“Ryan is a visionary, innovative, thoughtful and patient centric leader in the industry. His background with regards to understanding the market opportunities for small, disposable cameras is a perfect match for where our business is headed,” said CEO and President, Mark Foster. “Trice is building a large business in small procedures and we are looking forward to Ryan’s contributions.”
“We are at the very beginning of a massive wave of change in the way disposable cameras will be used, to unlock value throughout the global healthcare world. Many of these future innovations will enable healthcare providers to deliver better patient outcomes, with more efficiency. I am very excited to join the talented team at Trice to help bring their vision to life,” said Chief Commercial Officer, Ryan Hartman.
About Trice Medical:
At Trice Medical, our mission is to Build a Great Company That Enhances Quality of Life. We continuously strive to improve physician experience and patient outcomes by delivering cutting-edge, minimally invasive, imaging solutions for faster diagnosis and recovery.
To learn more about Trice Medical, headquartered in Malvern, PA, visit www.tricemedical.com.
Contact:
Trice Medical
(610) 989-8080
press@TriceMedical.com